Myocardial InfarctionDisease Models, AnimalMesenchymal Stem Cell TransplantationInjectionsMyocardiumVentricular RemodelingMyocytes, CardiacNeovascularization, PhysiologicStem Cell TransplantationEchocardiographyMesenchymal Stromal CellsRats, Sprague-DawleyInfarctionPharmacologyPharmacology, ClinicalElectrocardiographyCerebral InfarctionAngioplasty, Balloon, CoronaryThrombolytic TherapyTime FactorsCoronary AngiographyAnterior Wall Myocardial InfarctionMyocardial ReperfusionRisk FactorsTreatment OutcomeProspective StudiesStreptokinaseDogsCreatine KinaseCoronary Care UnitsSwineVentricular Function, LeftFibrinolytic AgentsGenetic TherapyCoronary DiseasePlatelet Aggregation InhibitorsPrognosisAngina PectorisFollow-Up StudiesAngina, UnstablePredictive Value of TestsStentsPercutaneous Coronary InterventionMyocardial RevascularizationCoronary ThrombosisCoronary VesselsRecurrenceMyocardial IschemiaRisk AssessmentShock, CardiogenicCoronary Artery DiseaseInferior Wall Myocardial InfarctionVentricular Dysfunction, LeftHospital MortalityCoronary CirculationStroke VolumeAcute DiseaseRetrospective StudiesChest PainBiological MarkersHeartHeart FailureCoronary Artery BypassProportional Hazards ModelsRegistriesIncidenceAspirinStrokeHeart VentriclesAcute Coronary SyndromeArrhythmias, CardiacCohort StudiesTissue Plasminogen ActivatorSurvival AnalysisHeart Rupture, Post-InfarctionMultivariate AnalysisHospitalizationHemorrhageClinical Enzyme TestsCase-Control StudiesDrug-Eluting StentsCardiovascular AgentsAdrenergic beta-AntagonistsCardiac CatheterizationTroponin TRiskHemodynamicsDeath, Sudden, CardiacTroponin IMyocardial Reperfusion InjuryLogistic ModelsCardiovascular DiseasesCardiotonic AgentsSurvival RateTiclopidineThrombosisAge FactorsRandomized Controlled Trials as TopicKaplan-Meier EstimateChi-Square Distribution